Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
USL261 Safety Study in Seizure Clusters
NCT02161185Phase 3Terminated
- Sponsor
- UCB
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midazolam in seizure cluster, sponsored by UCB. Started May 2014; status: terminated.
02
Drugs
midazolam
03
Conditions
seizure cluster
Beyond the preview
Go deeper on NCT02161185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02161185.